Icon

FIRAZYR (nda022150)- (EQ 30MG BASE/3ML (EQ 10MG BASE/ML))

ICATIBANT ACETATE TAKEDA PHARMS USA
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Yes No
2019-Jul-15 2016-Aug-25
2018-Aug-25 None
None No
FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
9 0 9
Total Other Developers 16
Drugs with Suitability No
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ********* **** ******* *********** ************* ** ** ** *********** *, ****, ********, ******* ****, ****, ******* (***) ***
****** **** ****** *** **** ************** ********** ***. *********** ** *** ******* ******, ********** ****, **** ****, *******, ****** (***) ***
****** ******** ****** *** ****** ****** *.*.* *********** *** *******, *, *********, ****** *****, ***** (***) ***
****** **** ***** ***** ** **** ***** ************** **. ***. *********** **. ****, ********* ****, ****** ****, ****** ******** *****, ****** (***) ***
****** ***** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** *** ******** ** *** *********** ***. ***. *** *******-*** ****** **, ** ***** ***
****** ******** ****** *** ******** *************** ***., *** *********** **** ******** **, ******, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ****** **** ******** ******* *** *********** ****** **. ** & **, *** *****, ********** *******, ***** ******, ********** ********, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ******** ***, **** **. ****/****, ******* - *********, ****** - *****, ********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.